---
document_datetime: 2024-08-20 12:05:51
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/bekemv-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
document_name: bekemv-epar-procedural-steps-taken-scientific-information-after-authorisation-archive_en.pdf
version: success
processing_time: 1.3855872
conversion_datetime: 2025-12-24 16:09:09.705097
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## BEKEMV

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                            | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0005              | B.I.b.2.d - Change in test procedure for AS or starting material/reagent/intermediate - Substantial change to or replacement of a biological/immunological/immunochemical test method or a method using a biological reagent for a biological AS | 27/06/2024                          | n/a                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| PSUSA/1198/ 202310   | Periodic Safety Update EU Single assessment - eculizumab                                                                                                                                                                                                     | 16/05/2024   | n/a        |                        | PRAC Recommendation - maintenance   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|-------------------------------------|
| IB/0004              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 07/05/2024   | 22/05/2024 | SmPC, Labelling and PL |                                     |
| IB/0002              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 02/02/2024   | 22/05/2024 | SmPC and PL            |                                     |
| N/0001               | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                             | 22/06/2023   | 22/05/2024 | PL                     |                                     |